inclusion criteria: * confirmed case of covid-19 in national reference hospitals - covid sentinel hospitals. * male and female patients 18 to 75 years (inclusive) of age. * supply of signed and dated informed consent form * declared availability to comply with all study procedures and availability for the duration of the study. * in good general health with mild or moderate symptoms during the first week of disease evolution (onset of symptoms maximum 7 days before recruitment). * ability to take oral medications and be willing to adhere to the medication consumption regimen prescribed in the study. * the patient must, in the opinion of the principal investigator, be able to comply with all the requirements of the clinical trial (including home monitoring during isolation). * the patient is able and willing to comply with the requirements of this test protocol. voluntarily signed informed consent obtained prior to any proceeding related to the trial.

inclusion criteria: * confirmed case of covid-19 in national reference hospitals - covid sentinel hospitals. * male and female patients 18 to 75 years (inclusive) of age. * supply of signed and dated informed consent form * declared availability to comply with all study procedures and availability for the duration of the study. * in good general health with mild or moderate symptoms during the first week of disease evolution (onset of symptoms maximum 7 days before recruitment). * ability to take oral medications and be willing to adhere to the medication consumption regimen prescribed in the study. * the patient must, in the opinion of the principal investigator, be able to comply with all the requirements of the clinical trial (including home monitoring during isolation). * the patient is able and willing to comply with the requirements of this test protocol. voluntarily signed informed consent obtained prior to any proceeding related to the trial.

inclusion criteria: - confirmed case of covid-19 in national reference hospitals - covid sentinel hospitals. - male and female patients 18 to 75 years (inclusive) of age. - supply of signed and dated informed consent form - declared availability to comply with all study procedures and availability for the duration of the study. - in good general health with mild or moderate symptoms during the first week of disease evolution (onset of symptoms maximum 7 days before recruitment). - ability to take oral medications and be willing to adhere to the medication consumption regimen prescribed in the study. - the patient must, in the opinion of the principal investigator, be able to comply with all the requirements of the clinical trial (including home monitoring during isolation). - the patient is able and willing to comply with the requirements of this test protocol. voluntarily signed informed consent obtained prior to any proceeding related to the trial.

inclusion criteria: - confirmed case of covid-19 in national reference hospitals - covid sentinel hospitals. - male and female patients 18 to 75 years (inclusive) of age. - supply of signed and dated informed consent form - declared availability to comply with all study procedures and availability for the duration of the study. - in good general health with mild or moderate symptoms during the first week of disease evolution (onset of symptoms maximum 7 days before recruitment). - ability to take oral medications and be willing to adhere to the medication consumption regimen prescribed in the study. - the patient must, in the opinion of the principal investigator, be able to comply with all the requirements of the clinical trial (including home monitoring during isolation). - the patient is able and willing to comply with the requirements of this test protocol. voluntarily signed informed consent obtained prior to any proceeding related to the trial.